![](/img/cover-not-exists.png)
Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
Stewart, A. K., Dimopoulos, M. A., Masszi, T., pi ka, I., Oriol, A., Hajek, R., Rosinol, L., Siegel, D. S., Niesvizky, R., Jakubowiak, A. J., San-Miguel, J. F., Ludwig, H., Buchanan, J., Cocks, K., YLanguage:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2016.66.9648
Date:
September, 2016
File:
PDF, 990 KB
english, 2016